Bernd-Rüdiger Balda|Michael Hertl

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bernd-Rüdiger Balda

Michael Hertl

Showing results (151-160 of 180) with videos related to

Pageof 18

Sort By:

Cellular and Molecular Life Sciences : CMLS|July 14, 2023

Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesionSunil Yeruva, Konstanze Stangner, Anna Jungwirth, et al.

The Journal of Clinical Investigation|September 22, 2012

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interfaceGiovanni Di Zenzo, Giulia Di Lullo, Davide Corti, et al.

Nature Genetics|June 5, 2007

Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasiaKarl-Heinz Grzeschik, Dorothea Bornholdt, Frank Oeffner, et al.

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007

Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.

Experimental Dermatology|June 16, 2016

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiologyA Razzaque Ahmed, Marco Carrozzo, Frédéric Caux, et al.

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 18, 2021

Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needsMatthias Augustin, Gefion Girbig, Anne Kis, et al.

Journal of Cell Science|January 22, 2025

Meeting report - Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseasesJens Waschke, Masayuki Amagai, Christoph Becker, et al.

The Journal of Allergy and Clinical Immunology|November 22, 2020

Immunophenotyping in pemphigus reveals a T<sub>H</sub>17/T<sub>FH</sub>17 cell-dominated immune response promoting desmoglein1/3-specific autoantibody productionJulia Holstein, Farzan Solimani, Carolin Baum, et al.

Cell Reports|July 25, 2019

Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune DiseaseAlice Cho, Amber L Caldara, Nina A Ran, et al.

Archives of Dermatology|June 20, 2002

Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old ageBerthold Rzany, Karin Partscht, Martin Jung, et al.

Pageof 18

Search research articles

Showing results (151-160 of 180) with videos related to

Sort By:

Pageof 18

Cellular and Molecular Life Sciences : CMLS|July 14, 2023

Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesionSunil Yeruva, Konstanze Stangner, Anna Jungwirth, et al.

The Journal of Clinical Investigation|September 22, 2012

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interfaceGiovanni Di Zenzo, Giulia Di Lullo, Davide Corti, et al.

Nature Genetics|June 5, 2007

Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasiaKarl-Heinz Grzeschik, Dorothea Bornholdt, Frank Oeffner, et al.

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007

Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.

Experimental Dermatology|June 16, 2016

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiologyA Razzaque Ahmed, Marco Carrozzo, Frédéric Caux, et al.

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 18, 2021

Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needsMatthias Augustin, Gefion Girbig, Anne Kis, et al.

Journal of Cell Science|January 22, 2025

Meeting report - Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseasesJens Waschke, Masayuki Amagai, Christoph Becker, et al.

The Journal of Allergy and Clinical Immunology|November 22, 2020

Cell Reports|July 25, 2019

Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune DiseaseAlice Cho, Amber L Caldara, Nina A Ran, et al.

Archives of Dermatology|June 20, 2002

Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old ageBerthold Rzany, Karin Partscht, Martin Jung, et al.

Pageof 18